Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets
PR Newswire•27/10/2026•18:00 ET
0
Key Highlights
- ➤Nektar (NKTR) will report third-quarter 2026 results November 12 after market close
- ➤CEO Howard Robin will host the results conference call at 5:00 p.m. Eastern
- ➤REZPEG is being evaluated in atopic dermatitis, alopecia areata, and Type 1 diabetes
Expert Statements
Howard Robin, President and Chief Executive Officer of Nektar Therapeutics
“will host a conference call to review the results”
Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets PR Newswire
SAN FRANCISCO, Oct. 27, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
Get started
Create a free account to read the full story.